Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 474801 - 474820 out of 483426 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| USA | (L01FX17) sacituzumab govitecan | TRODELVY | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms;Triple Negative Breast Neoplasms | GileadSciences,Inc. |
| USA | (L01FX17) sacituzumab govitecan | TRODELVY | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms;Triple Negative Breast Neoplasms | GileadSciences,Inc. |
| USA | (L01FX18) amivantamab | RYBREVANT 350MG | 7ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
| USA | (L01FX18) amivantamab | RYBREVANT 350MG | 7ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
| USA | (L01FX20) tremelimumab | IMJUDO 20MG/ML INJ | 1.25ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Hepatocellular;Carcinoma, Non-Small-Cell Lung | ASTRAZENECAPHARMACEUTICALSLP |
| USA | (L01FX20) tremelimumab | IMJUDO 20MG/ML INJ | 15ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Hepatocellular;Carcinoma, Non-Small-Cell Lung | ASTRAZENECAPHARMACEUTICALSLP |
| USA | (L01FX20) tremelimumab | IMJUDO 20MG/ML INJ | 1.25ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Hepatocellular;Carcinoma, Non-Small-Cell Lung | ASTRAZENECAPHARMACEUTICALSLP |
| USA | (L01FX20) tremelimumab | IMJUDO 20MG/ML INJ | 15ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Hepatocellular;Carcinoma, Non-Small-Cell Lung | ASTRAZENECAPHARMACEUTICALSLP |
| USA | (L01FX22) loncastuximab tesirine | ZYNLONTA 10MG/VIAL INJ | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Lymphoma, Large B-Cell, Diffuse;Lymphoma, B-Cell | ADCTherapeuticsAmerica,Inc. |
| USA | (L01FX24) teclistamab | TECVAYLI 10MG/ML INJ,SOLN,3ML | 3ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
| USA | (L01FX24) teclistamab | TECVAYLI 10MG/ML INJ,SOLN,3ML | 3ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
| USA | (L01FX24) teclistamab | TECVAYLI 90MG/ML INJ,SOLN,1.7ML | 1.7ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
| USA | (L01FX24) teclistamab | TECVAYLI 90MG/ML INJ,SOLN,1.7ML | 1.7ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
| USA | (L01FX25) mosunetuzumab | LUNSUMIO 1MG/ML INJ,SOLN,1ML | 1ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Lymphoma, Follicular | GenentechUSA,Inc. |
| USA | (L01FX25) mosunetuzumab | LUNSUMIO 1MG/ML INJ,SOLN,1ML | 1ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Lymphoma, Follicular | GenentechUSA,Inc. |
| USA | (L01FX25) mosunetuzumab | LUNSUMIO 1MG/ML INJ,SOLN,30ML | 30ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Lymphoma, Follicular | GenentechUSA,Inc. |
| USA | (L01FX25) mosunetuzumab | LUNSUMIO 1MG/ML INJ,SOLN,30ML | 30ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Lymphoma, Follicular | GenentechUSA,Inc. |
| USA | (L01FX26) mirvetuximab soravtansine | ELAHERE 100MG INJ | 20ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Ovarian Neoplasms;Fallopian Tube Neoplasms;Peritoneal Neoplasms | ImmunoGen,Inc. |
| USA | (L01FX28) glofitamab | COLUMVI 1MG/ML INJ,SOLN | 10ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Lymphoma, Large B-Cell, Diffuse | GenentechUSA,Inc. |
| USA | (L01FX28) glofitamab | COLUMVI 1MG/ML INJ,SOLN | 10ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Lymphoma, Large B-Cell, Diffuse | GenentechUSA,Inc. |
Pages
